Literature DB >> 17451755

The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats.

Maria Sabrina Spano1, Liana Fattore, Walter Fratta, Paola Fadda.   

Abstract

Opiate addiction is a chronic relapsing disorder characterized by high rates of relapse. The gamma-aminobutyric acid GABA(B) receptor agonist baclofen is known to affect the reinforcing effects of several drugs of abuse, including heroin, as well as to decrease cue-maintained responding for heroin, cocaine and nicotine and suppress alcohol deprivation effect in rats. Here we studied the effect of baclofen on the reinstatement of extinguished heroin-seeking behavior triggered by a priming injection of heroin in abstinent rats trained to stably self-administer heroin (30 microg/kg per infusion) under a continuous reinforcement schedule. Following extinction, the effect of non-contingent non-reinforced primings with heroin, baclofen or heroin/baclofen combination on the resumption of responding was evaluated. Results indicate that heroin priming (0.25mg/kg) promptly reinitiated heroin-seeking behavior, an effect dose-dependently reduced by baclofen at doses (0.625 and 1.25mg/kg) not affecting responding per sè. Importantly, baclofen did not affect locomotion either alone or in combination with heroin, dispelling any doubt as to the eliciting of possible non-specific (motor) effects. The present results show that GABA(B) receptor activation may reduce the propensity to resume drug-induced heroin-seeking behavior thus offering a possible approach in maintaining opiate abstinence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451755     DOI: 10.1016/j.neuropharm.2007.02.012

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  23 in total

1.  Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Authors:  L Fattore; Ms Spano; V Melis; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2014-07-12       Impact factor: 3.332

Review 3.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

4.  The use of opioids in children receiving intrathecal baclofen therapy.

Authors:  Giuliana Rizzo; Leonardo Bussolin; Lorenzo Genitori; Anna Zicca; Andrea Messeri; Matteo Lenge; Flavio Giordano
Journal:  Childs Nerv Syst       Date:  2019-04-26       Impact factor: 1.475

Review 5.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

6.  Constitutive activity of 5-HT2C receptors is present after incomplete spinal cord injury but is not modified after chronic SSRI or baclofen treatment.

Authors:  V M Tysseling; D A Klein; R Imhoff-Manuel; M Manuel; C J Heckman; M C Tresch
Journal:  J Neurophysiol       Date:  2017-09-06       Impact factor: 2.714

7.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

8.  The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.

Authors:  Teresa R Franklin; Derek Harper; Kyle Kampman; Susan Kildea-McCrea; Will Jens; Kevin G Lynch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2009-04-23       Impact factor: 4.492

9.  Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen.

Authors:  Linda J Porrino; Robert E Hampson; Ioan Opris; Samuel A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2012-07-27       Impact factor: 4.530

Review 10.  Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?

Authors:  Philip G Haydon; Julie Blendy; Stephen J Moss; F Rob Jackson
Journal:  Neuropharmacology       Date:  2008-07-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.